European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunity Immunization 111

Pharma Marketing Network

DECEMBER 17, 2021

Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022. This is likely something we will be living with until we crack the code on how to vaccinate the unvaccinated, and even then we’re all likely to be getting boosters for a long-time.

Customer Service 105

Customer Service Vaccines Communication 105

pharmacy mentor

JANUARY 11, 2023

2022 managed to both whizz by, and also be a year in which we achieved so much for our Pharmacy clients! Here’s our round-up of what we learned in 2022, as well as what we look forward to in 2023. 12 New Positions hired 14 New TrustPilot reviews Client Wins and Growth There were some really great client wins in 2022.

Communication 52

Communication Community Pharmacies Vaccines 52

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. per 100,000 people were hospitalised for RSV-related reasons in the 2022–23 RSV season. per 100,000.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

European Pharmaceutical Review

AUGUST 15, 2022

According to Reuters , Kenya, Tanzania, Senegal and Cameroon have either run out of or are close to running out of vaccines to protect children against the deadly rotavirus infection following undisclosed “manufacturing challenges” at GSK. We are witnessing the largest sustained drop in childhood immunisation in a generation.

Vaccines 98

Vaccines Communication 98

Digital Pharmacist

NOVEMBER 21, 2022

On October 7 th , 2022 the U.S. b) Marketing and Communications Oversight. Medicare beneficiaries will be secured by CMS’s finalization of revisions to marketing and communications regulations that will guarantee they get accurate and understandable information about their coverage. Road Towards Approval.

Communication 98

Communication Documentation Pharmacy Management Immunity 98

pharmaphorum

NOVEMBER 27, 2022

Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Eye on FDA

JANUARY 26, 2023

This year is a telling one and FDA may be changing the nature of the way they are communicating with the public. Overall Fewer Press Releases – During 2022 the agency issued fewer press releases than in most previous years – 237 down from 285 the previous year and the fewest releases since 2017.

Communication 60

Communication Vaccines 60

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. CEVEC became part of Cytiva in October 2022.

Communication 97

Communication Dosage Packaging Vaccines 97

Pharmaceutical Technology

MARCH 22, 2023

Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Due to the cessation of Russian gas imports following its invasion of Ukraine, electricity prices increased up to tenfold, and raw material costs rose by 50% to 160% in Q3 2022.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

pharmaphorum

SEPTEMBER 21, 2022

Meanwhile, Prescript Communications – which had designed Novartis’ Kesimpta Digital Training Portal, the Bronze winner of the Internal Communications category – said that the company itself had been fortunate to undergo its own creative digitalisation makeover process before being approached for the project, having foreseen developing trends.

Communication 78

Communication Vaccines 78

Putting Patients First Blog

APRIL 30, 2024

This method not only prioritizes the participant’s comprehension but also aligns with best practices in health communication that suggests a focused approach can significantly enhance understanding and retention of important information. The importance of using plain language in health communications is well-documented in literature.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

Putting Patients First Blog

OCTOBER 3, 2023

NHC 2022 ANNUAL REVENUE REPORT SUMMARY DISCUSSION October 3, 2023 By: Bhriana Onuoha, Senior Communications Coordinator On Oct. NHC 2022 ANNUAL REVENUE REPORT SUMMARY DISCUSSION October 3, 2023 By: Bhriana Onuoha, Senior Communications Coordinator On Oct.

Communication 52

Communication Vaccines 52

European Pharmaceutical Review

JUNE 16, 2023

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.

Communication 111

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 111

pharmaphorum

MARCH 15, 2022

Towards the conclusion of 2021 many societies announced another shift in format; 2022 conferences would be hybrid, or increasingly and more realistically described as ‘physical with virtual participation options,’ or similar. Part 2 will assess possible scenarios for 2022 and beyond. yes, if vaccines are available; 15.8%

Labelling 105

Labelling Vaccines Communication 105

Eye on FDA

JANUARY 12, 2022

Each year we look back to take stock of how the agency has been communicating in the course of the previous year and assess how that might compare to years gone by. When Dr. Scott Gottlieb took the reins of FDA as Commissioner, the amount of communications material put out jumped enormously. When will the products be fully approved?

Communication 73

Communication Vaccines 73

Pharmaceutical Technology

MARCH 20, 2023

But these boom years gave way to retrenchment in 2022 as investors balked at rising inflation and supply chain pressures. In the fourth quarter of 2022, the most recent period for which data is available, GlobalData estimates suggest the value of venture capital investment in pharmaceutical firms worldwide was $7.8 Source: GlobalData.

Vaccines 90

Vaccines Communication Hospitals 90

European Pharmaceutical Review

NOVEMBER 16, 2022

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. 2022 Access to Medicine Index findings. 2022 Access to Medicine Index findings.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 98

Pharmaceutical Technology

JUNE 13, 2023

The FDA approved Adstiladrin for the treatment of high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors in adult patients in December 2022. The company aims to then increase supplies in 2024.

Vaccines 98

Vaccines Chemotherapy Communication 98

Pharma Marketing Network

JANUARY 6, 2021

Trend #1: Media and Tech: Facilitating Communication. The use of artificial intelligence and machine learning will also increase in 2021 and is expected to become an $8 billion industry by 2022. For example, people mistrust the efficiency and safety of the COVID-19 vaccine.

Communication 98

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

Eye on FDA

FEBRUARY 22, 2022

Communications regarding aspects of agency work vis a vis the pandemic fell in 2021 compared to the year before, despite the number of developments in vaccines and therapeutics during the year. Looking at it on a month by month basis, you get a real impression of how much oxygen COVID-19 took of FDA’s communications.

Communication 75

Communication Vaccines 75

National Association of Boards of Pharmacy

JULY 22, 2022

Many pharmacists can now administer diagnostic tests and vaccines, as well as dispense treatments for coronavirus disease 2019 (COVID-19). Telehealth capabilities were also expanded, allowing patients in rural or underserved communities to access pharmacist care. Updates will be posted on the NABP website and other communications.

Pharmacy Technician 52

Pharmacy Technician Communication Documentation Vaccines 52

pharmaphorum

DECEMBER 2, 2022

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Frontiers Health 2022. Create, approve, deploy: supercharging communications with modular content.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 12, 2022

Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has shelved plans to offer treatment with AstraZeneca’s antibody therapy Evusheld. — Kidney Care UK (@kidneycareuk) August 12, 2022.

Vaccines 145

Vaccines Communication 145

pharmaphorum

JANUARY 17, 2023

Marjo Loisa, the director of communications at THL, told the newspaper that “90% of tweets related to the coronavirus are highly inappropriate, and people are joining other discussions with disinformation as well.” million accounts were challenged and 97,674 pieces of global content removed up to September 2022.

Communication 52

Communication Vaccines 52

Putting Patients First Blog

OCTOBER 5, 2023

October 5, 2023 By: Bhriana Onuoha, Senior Coordinator, Communications When striving to attain a goal, the leader’s role is to provide guidance, inspiration, and motivation. 10/05/2023 Read More NHC 2022 ANNUAL REVENUE REPORT SUMMARY DISCUSSION 10/03/2023 Read More Fall is Pumpkin Spice and Vaccine Season!

Communication 59

Communication Vaccines 59

The Happy PharmD

SEPTEMBER 15, 2024

Based on the data, the average distress level among pharmacists has decreased compared to previous reports spanning from 2019 to 2022. The strain on pharmacists can lead to errors, as evidenced by a pharmacist who almost administered the wrong vaccine dosage due to workload pressures. It has declined from 3.25 in 2019 to 2.59.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Dosage Documentation Communication 52

Pharmaceutical Technology

JANUARY 5, 2023

The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The outlook for global growth continues to deteriorate as inflation continues to significantly exceed the target of 2% in most developed markets.

Drug Pricing 69

Drug Pricing Vaccines Labelling Communication 69

pharmaphorum

SEPTEMBER 14, 2022

With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pandemic, eagerly learning about everything from symptoms to vaccine development. Long-term partners.

Vaccines 98

Vaccines Medical Records Documentation Communication 98

Pharmaceutical Technology

AUGUST 5, 2022

In March 2022, a UCL-based team from the MRC Prion Unit and Institute of Prion Diseases shared findings from a Phase I study that tested a mAb, PRN100, that they developed, in six patients. According to Mabbott, a challenge with developing mAbs or vaccines is their potential toxicity. Movement in imaging and exploratory therapeutics.

Vaccines 119

Vaccines Communication 119

pharmaphorum

OCTOBER 25, 2022

This is an ongoing challenge, and one that reared its head again during the pandemic, as questions over vaccine equity arose. At a more fundamental level, even the words used in scientific communication are facing scrutiny because of how they can affect people’s health outcomes.

Diabetes 96

Diabetes Vaccines Medical Records Communication 96

Pharmaceutical Technology

MARCH 22, 2023

In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. In 2022 alone, the company increased FirstLine capacity by 15%.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 25, 2023

Nearly 6,000 such trials were underway at the end of Q3 2022, with hundreds more in the pipeline. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The Covid-19 pandemic played a pivotal role in catalysing change.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 59

Viseven

OCTOBER 26, 2022

The global pandemic created an unprecedented demand for vaccines, shut down many clinical trials, and resulted in a worldwide PPE shortage. And now, almost at the end of 2022, the industry is still scrambling to catch up. While the vaccine was being developed, the industry found it difficult to display clinical trial protocols openly.

Hospitals 52

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 25, 2023

Nearly 6,000 such trials were underway at the end of Q3 2022, with hundreds more in the pipeline. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The Covid-19 pandemic played a pivotal role in catalysing change.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 52

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. Those available commercially include adenoviral-based vaccines by AstraZeneca and Johnson & Johnson. 2021 [Cited 16 September 2022].

Vaccines 115

Vaccines Documentation Communication Hospitals 115

European Pharmaceutical Review

JULY 21, 2023

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. The facility aims to support vaccination efforts at both national and international levels.

Vaccines 98

Vaccines Pharmaceutical Manufacturing Communication Hospitals 98